| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |